Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Method for differential diagnosis of T cell leukemias using monoclonal antibodies

Patent ·
OSTI ID:6700381
This patent describes monoclonal antibody 3-3 (HB8369) and 3-40 (HB8368) not capable of immunological reaction with normal, human peripheral T or B blood cell antigens, normal human thymocyte antigens or normal, human bone marrow precursor cell antigens but capable of immunological reaction with separate and distinct T-ALL leukemia antigens (T-ALL) having molecular weights of approximately 35-40,000 KD. The monoclonal antibodies are capable of distinguishing T-ALL leukemia from cutaneous T-cell lymphoma (CTCL), adult T cell leukemia (ATL) and T-cell chronic lymphocytic leukemia (T-CLL) and are further capable of subsetting T-ALL leukemia into E-Rosette positive and E-Rosette negative cells.
Assignee:
Memorial Sloan-Kettering Institute Cancer Center, New York, NY
Patent Number(s):
US 4645738
OSTI ID:
6700381
Country of Publication:
United States
Language:
English